67 related articles for article (PubMed ID: 38628712)
1. Predicting the risk of primary Sjögren's syndrome with key N7-methylguanosine-related genes: A novel XGBoost model.
Xie H; Deng YM; Li JY; Xie KH; Tao T; Zhang JF
Heliyon; 2024 May; 10(10):e31307. PubMed ID: 38803884
[TBL] [Abstract][Full Text] [Related]
2. Potential clinical application of microRNAs in bladder cancer.
Wang P; Wei X; Qu X; Zhu Y
J Biomed Res; 2024 Jan; ():1-18. PubMed ID: 38808545
[TBL] [Abstract][Full Text] [Related]
3. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B
Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712
[TBL] [Abstract][Full Text] [Related]
4. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
5. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
Gao Y; Ren J; Chen K; Guan G
J Gastrointest Oncol; 2024 Feb; 15(1):203-219. PubMed ID: 38482248
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
[TBL] [Abstract][Full Text] [Related]
7. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL
Front Genet; 2022; 13():930446. PubMed ID: 36110218
[No Abstract] [Full Text] [Related]
8. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
9. Genetic and clinical landscape of ER + /PR- breast cancer in China.
Dai D; Wu H; Zhuang H; Chen R; Long C; Chen B
BMC Cancer; 2023 Dec; 23(1):1189. PubMed ID: 38049758
[TBL] [Abstract][Full Text] [Related]
10. The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
Xie J; Zhang J; Tian W; Zou Y; Tang Y; Zheng S; Wong CW; Deng X; Wu S; Chen J; Mo Y; Xie X
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555288
[TBL] [Abstract][Full Text] [Related]
11. The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer.
Zou Y; Ye F; Kong Y; Hu X; Deng X; Xie J; Song C; Ou X; Wu S; Wu L; Xie Y; Tian W; Tang Y; Wong CW; Chen ZS; Xie X; Tang H
Adv Sci (Weinh); 2023 Feb; 10(5):e2203699. PubMed ID: 36529697
[TBL] [Abstract][Full Text] [Related]
12. METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m
Xie H; Wang M; Yu H; Wang H; Ding L; Wang R; Luo W; Lu Z; Zheng Q; Ren L; Zhou Z; Su W; Xia L; Li G
Cell Death Discov; 2022 Nov; 8(1):458. PubMed ID: 36396627
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumour-intrinsic N
Liu H; Zeng X; Ren X; Zhang Y; Huang M; Tan L; Dai Z; Lai J; Xie W; Chen Z; Peng S; Xu L; Chen S; Shen S; Kuang M; Lin S
Gut; 2023 Aug; 72(8):1555-1567. PubMed ID: 36283801
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
